Addex Pharmaceuticals S.A. (ADXN) Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright Co. LLC.

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 31, 2024 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based d [...]